期刊文献+

可降解与不可降解涂层雷帕霉素洗脱支架植入后高敏C反应蛋白和白细胞介素6水平变化 被引量:1

Changes of High Sensitivity C-Reactive Protein and Interleukin-6 Levels After Implantation of Degradable and Non-Degradable Coating with Siromulus Eluting Stents
暂未订购
导出
摘要 目的观察可降解涂层与不可降解涂层雷帕霉素药物洗脱支架植入后循环与局部高敏C反应蛋白和白细胞介素6水平变化。方法连续入选118例接受PCI治疗植入1枚支架的不稳定型心绞痛患者,分为不可降解涂层组(n=65)和可降解涂层组(n=53)。于术前、术后即刻、48h、7天及9月时抽取静脉血,术前、术后即刻及术后9月冠状动脉造影随访时以微导管抽取冠状动脉局部血液,测定高敏C反应蛋白和白细胞介素6水平。结果两组基本临床资料、PCI术情况无明显差异。两组术后即刻支架局部血清白细胞介素6水平较术前显著升高;术后48h和7天循环高敏C反应蛋白和白细胞介素6水平明显高于术前。两组间比较,PCI术前、术后即刻、48h、7天和9月时循环及局部高敏C反应蛋白和白细胞介素6水平均无明显差异。结论可降解涂层与不可降解涂层雷帕霉素洗脱支架对术后循环与局部炎症反应的影响可能相似。 Aim To observe the effects of degradable coating and non-degradable coating with sirolimus-eluting stents on systemic and local levels of high sensitivity C-reactive protein(hs-CRP)and interleukin-6(IL-6).Methods Consecutive 118 patients with unstable angina pectoris(UAP)with a stent implanted were involved and divided into non-degradable coating group(n=65)and degradable coating group(n=53).The serum concentrations of hs-CRP and IL-6 were determined before and immediately,at 48 hours,7 days,and 9 months after coronary intervention,and local levels in coronary were determined before and immediately,at 9 months after stent implantation.Results There was no significant difference in clinical and angiographic baseline characteristics and basic serum hs-CRP and IL-6 concentrations between the two groups.The local IL-6 levels increased immediately after stent implation in both group.The circulatory serum hs-CRP and IL-6 levels at 48 hours and 7 days after stenting were significantly higher in both group compared with baseline.When compared between the two groups,there was no significant difference of hs-CRP and IL-6 levels at 48 hours,7 days,and 9 months after stenting both in systemic and in local levels.Conclusion It seemed that degradable coating and non-degradable coating with sirolimus-eluting stents may display similar effects on systemic and local inflammation.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2010年第10期813-816,共4页 Chinese Journal of Arteriosclerosis
关键词 高敏C反应蛋白 白细胞介素6 药物洗脱支架 冠状动脉疾病 High Sensitivity C-Reactive Protein Interleukin-6 Drug-Eluting Stent Coronary Artery Disease
  • 相关文献

参考文献2

二级参考文献4

共引文献14

同被引文献29

  • 1郑金刚,高润霖,程树军,王春宁,钱杰,阮英茆,王清峙,袁晋青,孟亮,乔树宾,陈纪林.可降解雷帕霉素洗脱支架对猪冠状动脉支架置入术后内膜增生的影响[J].中国循环杂志,2004,19(3):190-193. 被引量:9
  • 2陈佳慧,沈雳,王齐兵,等.冠状动脉生物可降解支架设计与应用:材料学的进一步革新将带来什么?[J].中国组织工程研究,2014,18(30):4878-4888.
  • 3李君,李晓艳.左旋乳酸,无定型磷酸钙生物全降解支架置入猪冠状动脉6个月内的支架弹性回缩及有效性[C]//第二十五届长城国际心脏病学会议、亚太心脏大会2014暨国际心血管预防与康复会议论文集.2014:64.
  • 4Kakuta T, Tanaka R, Hyodo T, et al. Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients. Am J Kidney Dis. 2011;57(3):422-431.
  • 5MEND-CABG II Investigators, Alexander JH, Emery RW Jr, et al. Efficacy and safety of pyridoxal 5'-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial. JAMA. 2008;299(15): 1777-1787.
  • 6Shin S, Kim K J, Chang H J, et al. Impact of serum calcium and phosphate on coronary atherosclerosis detected by cardiac computed tomography. Eur Heart J. 2012;33(22):2873-2881.
  • 7Krajnc M, Pe~ovnik-Balon B, Hojs R, et al. Comparison of coronary artery calcification and some coronary artery calcification risk factors in patients on haemodialysis and in patients with type 2 diabetes. J Int Med Res. 2011;39(3):1006-1015.
  • 8Lan Z, Lyu Y, Xiao J, et al. Novel biodegradable drug-eluting stent composed of poly-L-lactic acid and amorphous calcium phosphate nanoparticles demonstrates improved structural and functional performance for coronary artery disease. J Biomed Nanotechnol. 2014; 10(7): 1194-1204.
  • 9Guzik T J, Chen W, Gongora MC, et al. Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease. J Am Coil Cardiol. 2008;52(22): 1803-1809.
  • 10He J, Reilly M, Yang W, et al. Risk factors for coronary artery calcium among patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort Study). Am J Cardiol. 2012;110(12):1735-1741.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部